0001225208-23-002133.txt : 20230216 0001225208-23-002133.hdr.sgml : 20230216 20230216182114 ACCESSION NUMBER: 0001225208-23-002133 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230216 DATE AS OF CHANGE: 20230216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONE HEISZ LESLIE CENTRAL INDEX KEY: 0001235408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 23639761 MAIL ADDRESS: STREET 1: C/O PUBLIC STORAGE STREET 2: 701 WESTERN AVENUE CITY: GLENDALE STATE: CA ZIP: 91201 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2023-02-16 0001099800 Edwards Lifesciences Corp EW 0001235408 STONE HEISZ LESLIE ONE EDWARDS WAY IRVINE CA 92614 1 Common Stock 2023-02-16 4 M 0 9671.0000 35.6767 A 37151.0000 D Common Stock 2023-02-16 4 S 0 9671.0000 76.8216 D 27480.0000 D Director Stock Option (Right to Acquire) 35.6767 2023-02-16 4 M 0 9671.0000 0.0000 D 2017-07-14 2023-07-13 Common Stock 9671.0000 0.0000 D This transaction was executed in multiple trades at prices ranging from $76.71 to $76.92. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. Linda J. Park, Attorney-in-Fact 2023-02-16